Boston Scientific Corporation (BSX) Covered Calls
Boston Scientific Corporation is a leading global developer and manufacturer of medical devices used in a broad range of interventional medical specialties. The company provides innovative solutions for cardiovascular, endoscopy, urology, and neuromodulation procedures. Its products are designed to diagnose and treat complex diseases including heart rhythm disorders, chronic pain, and digestive conditions, helping healthcare providers improve patient outcomes and reduce healthcare costs.
You can sell covered calls on Boston Scientific Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BSX (prices last updated Thu 1:05 PM ET):
| Boston Scientific Corporation (BSX) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 71.03 | -0.25 | 71.02 | 71.04 | 5.1M | 37 | 106 |
| Covered Calls For Boston Scientific Corporation (BSX) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 71 | 0.65 | 70.39 | 0.9% | 164% | |
| Apr 17 | 70 | 4.20 | 66.84 | 4.7% | 57.2% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Boston Scientific Corporation (BSX) is a global leader in the medical technology industry, specializing in less-invasive medical devices that address a wide variety of clinical needs. The company operates through a diversified portfolio focused on high-growth medical specialties, utilizing engineering and clinical data to drive innovation in surgical and interventional care.
Core Business and Products
- Cardiovascular: This is the company’s largest segment, featuring the WATCHMAN left atrial appendage closure device for stroke prevention and the Farapulse pulsed-field ablation system for treating atrial fibrillation. It also includes interventional cardiology products like drug-eluting stents and coronary imaging tools.
- Endoscopy and Urology: The company provides a vast array of devices for diagnosing and treating gastrointestinal and pulmonary conditions, including the AXIOS stent. In urology, it offers solutions for kidney stones, prostate health, and pelvic floor disorders, bolstered by the acquisition of specialized laser and surgical technologies.
- Neuromodulation: This segment focuses on implantable technologies to manage chronic pain and neurological movement disorders. Its deep brain stimulation and spinal cord stimulation systems provide therapeutic alternatives for patients who do not respond well to traditional pharmaceutical treatments.
Competitive Landscape
The medical device market is highly competitive and regulated. In the cardiovascular and electrophysiology sectors, the company competes directly with Medtronic, Abbott, and Johnson & Johnson. In the surgical and endoscopy fields, it faces competition from Stryker and Intuitive Surgical. Other notable rivals in specialized niches include Edwards Lifesciences and Becton Dickinson. The company often differentiates itself through aggressive research and development and the acquisition of emerging biotech firms to expand its peripheral vascular portfolio.
Strategic Outlook and Innovation
The company is focused on sustaining its category leadership by expanding into high-growth adjacencies within its core segments. Innovation efforts are currently centered on the global rollout of pulsed-field ablation technology, which is expected to redefine the standard of care for heart rhythm disorders. Management is also prioritizing digital health integration, using data analytics to enhance the performance of its implantable devices and improve procedural efficiency for physicians. Strategic capital allocation remains a priority, with an emphasis on acquiring disruptive technologies in urology and oncology to diversify revenue streams. By investing in global supply chain resilience and expanding its presence in emerging markets, the company aims to maintain its trajectory of above-market growth while addressing the evolving needs of an aging global population.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | PL covered calls | |
| 2. | SLV covered calls | 7. | TSLA covered calls | 2. | NVCR covered calls | |
| 3. | SPY covered calls | 8. | SOFI covered calls | 3. | FLY covered calls | |
| 4. | EEM covered calls | 9. | EWZ covered calls | 4. | RCAT covered calls | |
| 5. | IBIT covered calls | 10. | FXI covered calls | 5. | ONDS covered calls | |
Want more examples? BSV Covered Calls | BSY Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
